Showing results (271-280 of 317) with videos related to
Sort By:
Pageof 32
Haematologica|January 13, 2022
Clinical relevance of proteomic profiling in <i>de novo</i> pediatric acute myeloid leukemia: a Children's Oncology Group studyFieke W Hoff, Anneke D Van Dijk, Yihua Qiu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2023
Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid LeukemiaJason E Farrar, Jenny L Smith, Megan Othus, et al.Nature Genetics|January 11, 2024
A new genomic framework to categorize pediatric acute myeloid leukemiaMasayuki Umeda, Jing Ma, Tamara Westover, et al.NPJ Precision Oncology|August 1, 2024
Integrated drug resistance and leukemic stemness gene-expression scores predict outcomes in large cohort of over 3500 AML patients from 10 trialsAbdelrahman H Elsayed, Xueyuan Cao, Richard J Marrero, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid LeukemiaTamara P Miller, Yimei Li, Marko Kavcic, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2025
Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology GroupBenjamin J Huang, Lauren K Meyer, Todd A Alonzo, et al.Cancer Research|March 5, 2016
Genomic Profiling of Pediatric Acute Myeloid Leukemia Reveals a Changing Mutational Landscape from Disease Diagnosis to RelapseJason E Farrar, Heather L Schuback, Rhonda E Ries, et al.Blood Advances|May 3, 2021
Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemiaAllison J Kaeding, Sonali P Barwe, Anilkumar Gopalakrishnapillai, et al.JCO Precision Oncology|September 19, 2024
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I)Margaret E Macy, Rajen Mody, Joel M Reid, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2022
Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH TrialOlive S Eckstein, Carl E Allen, P Mickey Williams, et al.Pageof 32